002919.SHE Mingchen Health Co Ltd Class A
- Market cap
- CNY 4.33B
- P/E
- -
- P/B
- 5.22x
- ROE
- -6.3%
- Dividend yield
- 0.32%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 002919.SHE undervalued?
Graham numberThe Graham number of Mingchen Health Co Ltd Class A cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Mingchen Health Co Ltd Class A fundamental analysis
No fundamental analysis for Mingchen Health Co Ltd Class A yet.
Mingchen Health Co Ltd Class A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Mingchen Health Co Ltd Class A
Mingchen Health Co.,Ltd. engages in the development, production, and sale of personal health care products in China. The company operate through Daily Chemical Products and Online game segments. It offers skin care, shampoo, hair care, bath products and styling products under the Dihua Zhixiu, DIFASO, SunShine Fruit Oil, Mei Wang, First Collection, Golden Lion, Likoujian, High Tech Health, Green Effect, Yicai, Xiao Qiqi, and Fice brand name. In addition, the company offers o…
Full company profileMingchen Health Co Ltd Class A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Mingchen Health Co Ltd Class A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 596M | 642M | 546M | 517M | 681M | 744M | 945M | 1.64B | 1.38B | 1.51B | 1.83B |
| Gross Profit | 217M | 240M | 200M | 188M | 273M | 366M | 488M | 977M | 714M | 820M | 1.04B |
| Operating Income | 54.1M | 55.7M | 31.8M | 27.0M | 105M | 127M | -5.46M | 57.9M | 31.3M | 22.0M | -33.7M |
| EBITDA | 64.6M | 65.2M | 44.1M | 35.7M | 119M | 147M | 54.4M | 206M | 57.2M | 79.2M | -53.2M |
| Net Income | 47.4M | 48.5M | 29.7M | 23.1M | 102M | 133M | 25.4M | 70.4M | 46.7M | 28.3M | -47.5M |
| EPS | 0.24 | 0.24 | 0.11 | 0.09 | 0.38 | 0.50 | 0.09 | 0.26 | 0.18 | 0.11 | -0.18 |
| Balance Sheet | |||||||||||
| Total Assets | 517M | 685M | 699M | 700M | 879M | 970M | 1.24B | 1.27B | 1.10B | 1.28B | 1.28B |
| Total Liabilities | 230M | 147M | 148M | 134M | 224M | 213M | 504M | 464M | 280M | 478M | 527M |
| Shareholders' Equity | 287M | 538M | 551M | 565M | 655M | 758M | 739M | 810M | 823M | 807M | 759M |
| Cash & Short-term Investments | 251M | 424M | 163M | 424M | 314M | 263M | 136M | 169M | 231M | 238M | 198M |
| Total Debt | - | - | - | - | 39.0M | 24.4M | 87.8M | 26.2M | 23.0M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 84.8M | -26.7M | 3.19M | 39.8M | 171M | 79.9M | 73.3M | 69.3M | 165M | 87.7M | - |
| Capital Expenditure | 13.1M | 9.68M | 12.6M | 17.5M | 13.9M | 15.5M | 151M | 12.7M | 48.6M | 86.5M | 31.9M |
| Free Cash Flow | 71.7M | -36.3M | -9.38M | 22.4M | 157M | 64.4M | -77.3M | 56.6M | 117M | 1.14M | -35.9M |
| Ratios | |||||||||||
| ROE | 16.5% | 9.0% | 5.4% | 4.1% | 15.6% | 17.6% | 3.4% | 8.7% | 5.7% | 3.5% | -6.3% |
| ROA | 9.2% | 7.1% | 4.2% | 3.3% | 11.6% | 13.8% | 2.0% | 5.5% | 4.2% | 2.2% | -3.7% |
| Net Profit Margin | 8.0% | 7.6% | 5.4% | 4.5% | 15.0% | 17.9% | 2.7% | 4.3% | 3.4% | 1.9% | -2.6% |
| Debt to Equity | - | - | - | - | 0.06x | 0.03x | 0.12x | 0.03x | 0.03x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Mingchen Health Co Ltd Class A dividends
- Dividend yield
- 0.32%
- Forward dividend
- 0.05 CNY
- Payout ratio
- 48.7%
- Ex-dividend date
- Jun 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 13.8M | 0.05 | 48.7% |
| 2024 | CNY 33.3M | 0.13 | 71.2% |
| 2023 | - | - | - |
| 2022 | CNY 36.6M | 0.13 | 144.3% |
| 2021 | CNY 31.1M | 0.12 | 23.3% |
| 2020 | CNY 12.2M | 0.05 | 11.9% |
| 2019 | CNY 8.14M | 0.03 | 35.3% |
| 2018 | CNY 16.3M | 0.06 | 54.9% |
| 2017 | CNY 15.3M | 0.08 | 31.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.2:1 on May 31, 2024.
Who owns Mingchen Health Co Ltd Class A
- Insiders 45.65%
- Institutions 3.54%
- Public & others 50.81%
- Shares outstanding 266M
- Free float 159M
Mingchen Health Co Ltd Class A company profile
- Company name
- Mingchen Health Co Ltd Class A
- Ticker
- 002919.SHE
- ISIN
- CNE1000033B9
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 1,305
- Fiscal year end
- December
- Address
- Liannan Industrial Zone, Shantou, China, 515834
- Phone
- 86 75 48511 5109
- Website
- mingchen.com.cn
About Mingchen Health Co Ltd Class A
Mingchen Health Co.,Ltd. engages in the development, production, and sale of personal health care products in China. The company operate through Daily Chemical Products and Online game segments. It offers skin care, shampoo, hair care, bath products and styling products under the Dihua Zhixiu, DIFASO, SunShine Fruit Oil, Mei Wang, First Collection, Golden Lion, Likoujian, High Tech Health, Green Effect, Yicai, Xiao Qiqi, and Fice brand name. In addition, the company offers online game operation services. Mingchen Health Co.,Ltd. was founded in 1994 and is based in Shantou, China.
Mingchen Health Co Ltd Class A management
4- Mr. Jianming ChenChairman & GM · born 1990
- Mr. Xiaoqing PengVice Chairman, Deputy GM & CFO · born 1970
- Mr. Dongsong ChenSecretary of the Board, Deputy GM & Non-Independent Director · born 1970
- Yaolin LinAccounting Supervisor